Delivery Order SPE2DB20D2104-SPE2DB25FMYNP
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,568.99 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,620.37 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors, with a completion deadline of July 21, 2025. This is a firm fixed price, non-set-aside contract executed on July 18, 2025, with performance at the company's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,810.50 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 18, 2025, with completion scheduled for September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The sensors will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,008.65 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on April 25, 2025, with an ultimate completion date of April 28, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $10,128.00 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,439.80 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,788.78 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This firm fixed-price contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive, non-set-aside award. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,234 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYNPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,846.23 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract with performance location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical and medical supply vehicle running through December 2026 that enables the company to serve military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a substantial federal contracting presence as a critical supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for continuous glucose monitoring sensors reflects the company's established capability to fulfill federal medical procurement requirements through competitive processes and represents a routine transaction within the broader pharmaceutical supply relationship between DLA and the contractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 8/21/25 |